Literature DB >> 12215720

Recent developments in hormonal contraception.

Eleanor A Drey1, Philip D Darney.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12215720     DOI： 10.1023/a:1020080627635

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  44 in total

1.  Transdermal contraception: evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study.

Authors:  Richard Dittrich; Lamar Parker; Jeffrey B Rosen; Gary Shangold; George W Creasy; Alan C Fisher
Journal:  Am J Obstet Gynecol       Date:  2002-01       Impact factor: 8.661

2.  Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lunelle Study Group.

Authors:  A M Kaunitz; R J Garceau; M A Cromie
Journal:  Contraception       Date:  1999-10       Impact factor: 3.375

Review 3.  The levonorgestrel intrauterine system: therapeutic aspects.

Authors:  T Luukkainen
Journal:  Steroids       Date:  2000 Oct-Nov       Impact factor: 2.668

4.  A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.

Authors:  S R Zheng; H M Zheng; S Z Qian; G W Sang; R F Kaper
Journal:  Contraception       Date:  1999-07       Impact factor: 3.375

5.  Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.

Authors:  I Sivin; J Stern; S Diaz; M Pavéz; F Alvarez; V Brache; D R Mishell; M Lacarra; T McCarthy; P Holma
Journal:  Am J Obstet Gynecol       Date:  1992-04       Impact factor: 8.661

6.  Introductory study of the once-a-month, injectable contraceptive Cyclofem in Brazil, Chile, Colombia, and Peru.

Authors:  P Hall; L Bahamondes; J Diaz; C Petta
Journal:  Contraception       Date:  1997-12       Impact factor: 3.375

7.  Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation.

Authors: 
Journal:  Lancet       Date:  1998-08-08       Impact factor: 79.321

8.  Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

Authors: 
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

9.  Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

Authors: 
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

10.  Intrauterine devices and pelvic inflammatory disease: an international perspective.

Authors:  T M Farley; M J Rosenberg; P J Rowe; J H Chen; O Meirik
Journal:  Lancet       Date:  1992-03-28       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.